Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · IEX Real-Time Price · USD
1.480
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
1.520
+0.040 (2.70%)
Pre-market: Jul 22, 2024, 7:05 AM EDT
Atai Life Sciences Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Atai Life Sciences stock have an average target of 12, with a low estimate of 6.00 and a high estimate of 15. The average target predicts an increase of 710.81% from the current stock price of 1.48.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 17, 2024.
Analyst Ratings
The average analyst rating for ATAI stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +913.51% | May 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 4, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $6 | Hold → Strong Buy | Upgrades | $6 | +305.41% | Apr 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $15 | Strong Buy | Maintains | $20 → $15 | +913.51% | Apr 3, 2024 |
Financial Forecast
Revenue This Year
306.00K
from 314.00K
Decreased by -2.55%
Revenue Next Year
306.00K
from 306.00K
EPS This Year
-0.65
from -0.25
EPS Next Year
-0.70
from -0.65
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.6M | 1.6M | 193.0M | 710.4M | 1.5B |
| Avg | 306,000 | 306,000 | 37.8M | 131.2M | 411.7M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 401.6% | 414.7% | 62,968.6% | 1,779.4% | 1,024.2% |
| Avg | -2.5% | - | 12,253.3% | 247.1% | 213.8% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.61 | -0.56 | -0.47 | 3.43 | 7.88 |
| Avg | -0.65 | -0.70 | -0.71 | 1.30 | 3.29 |
| Low | -0.71 | -0.82 | -0.96 | -0.72 | -1.02 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 507.9% |
| Avg | - | - | - | - | 154.3% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.